DNA damage induced by micellar-delivered doxorubicin and ultrasound: Comet assay study

Cancer Letters

Volumn 154, Issue 2, 2000, Pages 211-216

  Husseini, Ghaleb A ^a   El Fayoumi, Refaat I ^b   O'Neill, Kim L ^c   Rapoport, Natalya Y ^d   Pitt, William G ^a  

^a Department of Electrical and Computer Engineering   (United States)

^b MANSOURA UNIVERSITY   (Egypt)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

^d Department of Electrical and Computer Engineering   (United States)

Author keywords

Comet assay; Doxorubicin; Micellar drug delivery; Ultrasound

Indexed keywords

DOXORUBICIN; DRUG CARRIER; POLOXAMER;

ARTICLE; CELL STRAIN HL 60; CELL VIABILITY; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MICELLE; PRIORITY JOURNAL; ULTRASOUND;

COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HL-60 CELLS; HUMANS; MICELLES; TIME FACTORS; ULTRASONOGRAPHY;

EID: 0034733949     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00399-2     Document Type: Article

References (22)

1. Munshi N., Rapoport N., Pitt W.G. Ultrasonic activated drug delivery from pluronic P-105 micelles. Cancer Lett. 117:1997;1-7.
2. Rapoport N.Y., Herron J.N., Pitt W.G., Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, Ruboxyl to HL-60 cells: effect of micelle structure on the intracellular drug uptake. J. Control. Rel. 58:(2):1999;153-162.
3. Alakhov V.Y., Moskaleva E.Y., Batrakova E., Kabanov A.V. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P-85 block copolymer. Bioconj. Chem. 7:1996;209-216.
4. Kabanov A.V., Batrakova E.V., Melik-Nubarov N.S., Fedoseev N.A., Dorodnich T.Y., Alakhov V.Y., Nazarova I.R., Katanov V.A. A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for targeting drugs from blood to brain. J. Control. Rel. 22:1992;141-158.
5. Stolnic S., Illum L., Davis S.S. Long circulating microparticulate drug carriers. Adv. Drug Del. Rev. 16:1995;195-214.
6. Halperin A., Alexander S. Polymeric micelles: their relaxation kinetics. Macromolecules. 22:1989;2403-2412.
7. Kwon G.S., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Biodistribution of micelle-forming polymer-drug conjugates. Pharmacol. Res. 10:1993;970-974.
8. Rapoport N., Munshi N., Pitina L., Pitt W.G. Pluronic micelles as vehicles for tumor-specific delivery of two anti-cancer drugs to HL-60 cells using acoustic activation. Polymer Preprints. 38:(2):1997;620-621.
9. Saad A.H., Hahn G.M. Ultrasound enhances adriamycin toxicity in vitro. Chato J.C. Heat Transfer in Bioengineering and Medicine. 1987;28-31 American Society of Mechanical Engineering Press, New York.
10. Saad A.H., Hahn G.M. Ultrasound enhanced drug toxicity on Chinese hamster Ovary cells in vitro. Cancer Res. 49:1989;5931-5934.
11. Saad A.H., Hahn G.M. Ultrasound-enhanced effects of adriamycin against murine tumors. Ultrasound Med. Biol. 18:(8):1992;715-723.
12. Jeffers R.J. Activation of Anticancer Drugs with Ultrasound. 1995.
13. Tata D.B., Biglow J., Wu J.R., Tritton T.R., Dunn F. Ultrasound-enhanced hydroxyl radical production from two clinically employed anticancer drugs, adriamicin and mitomicin C. Ultrasonics Sonochem. 3:(1):1996;39-45.
14. Tata D.B., Hahn G., Dunn F. Ultrasonic absorption frequency dependence of two widely used anti-cancer drugs: doxorubicin and daunorubicin. Ultrasonics. 31:(6):1993;447-450.
15. Loverock P., Ter Haar G., Ormerod M.G., Imrie P.R. The effect of ultrasound on the cytotoxicity of adriamycin. Br. J. Radiol. 63:1990;542-546.
16. Ning S., Macleod K., Abra R., Huang A.H., Hahn G.M. Hyperthermia induced doxorubicin release from long-circulating liposomes and enhanced their anti-tumor efficacy. Int. J. Radiat. Oncol. Phys. 29:(4):1994;827-834.
17. Gilman A.G., Hardman J.G., Limbird L.E., Molinoff P.B. Ruddon, Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th Edition :1996;McGraw-Hill, New York.
18. Nip J., Strom D.K., Fee B.F., Zambetti G., Cleveland J.L., Hiebert S.W. cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17:(3):1997;1049-1056.
19. Fairbairn D.W., Oliver P.L., O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 339:1995;37-59.
20. Rapoport N., Pitina L. Intracellular distribution and intracellular dynamics of a spin-labeled analog of doxorubicin. J. Pharm. Sci. 87:(3):1998;321-325.
21. Fairbairn D.W., Walburger D.K., Fairbairn J.J., O'Neill K.L. Key morphologic changes and DNA strand breaks in human lymphoid cells: discriminating apoptosis from necrosis. Scanning. 18:1996;407-416.
22. Smith M.J., O'Neill K.L. Microscope slides for enhanced analysis of DNA damage using comet assay. Biotechniques. 25:1998;49-50.